The potential of continuous processing methodologies to reduce variability while increasing efficiency, productivity, and time-to-market are well proven in a range of industries—and has brought the same benefits to the pharmaceutical value chain. In this webinar, Malcolm Berry, Ph.D., a recognized leader in developing continuous processes for small molecule active pharmaceutical ingredients (APIs), discusses challenges with implementation and key observations; and Eric Edwards, MD, Ph.D., CEO and Co-Founder of Phlow, covers how continuous processing is helping Phlow bring new levels of efficiency and quality to the organization’s contract development and manufacturing services, in turn helping pharmaceutical and biotech companies of all sizes reduce production costs, decrease development time, and lower their environmental impact.
